Skip to main content
[Preprint]. 2024 Sep 12:2024.09.12.24313545. [Version 1] doi: 10.1101/2024.09.12.24313545

Figure 2. Effectiveness of nirsevimab against medically attended RSV, by clinical setting and severity.

Figure 2.

Adjusted models controlled for age, calendar month, and the presence of at least one risk factor (see Table S2).